References
- Sørensen S. M., Mortensen F. V., Nielsen D. T. Radiofrequency ablation of colorectal liver metastases: long-term survival. Acta Radiol 2007; 48: 253–8
- Figueras J., Torras J., Valls C., Llado L., Ramos E., Martin-Raguè J., et al. Surgical resection of colorectal liver metastases in patients with expanded indications: a single-center experience with 501 patients. Dis Colon Rectum 2007; 50: 478–8
- Fong Y., Fortner J., Sun R. L., Brennan M. F., Blumgart L. H. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 1999; 230: 309–18
- Minagawa M., Makuuchi M., Torzilli G., Takayama T., Kawasaki S., Kosuge T., et al. Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer: long-term results. Ann Surg 2000; 231: 487–99
- Iwatsuki S., Dvorchik I., Madariaga J. R., Marsh J. W., Dodson F., Bonham A. C., et al. Hepatic resection for metastatic colorectal adenocarcinoma: a proposal of a prognostic scoring system. J Am Coll Surg 1999; 189: 291–9
- Elias D., Sideris L., Pocard M., de Baere T., Dromain C., Lasau N., et al. Incidence of unsuspected and treatable metastatic disease associated with operable colorectal liver metastases discovered only at laparotomy (and not treated when performing percutaneous radiofrequency ablation). Ann Surg Oncol 2005; 12: 298–302
- Figueras J., Planellas P., Albiol M. T., Lopez-Ben S., Soriano J., Codina-Barreras A., et al. Role of intraoperative ultrasound and multidetector computed tomography in surgery for colorectal liver metastases: a prospective study (accepted for publication in Cirugia Española)
- Jarnagin W. R., Bach A. M., Winston C. B., Haan L. E., Heffernan N., Loumeau T., et al. What is the yield of intraoperative ultrasonography during partial hepatectomy for malignant disease?. J Am Coll Surg 2001; 192: 577–83
- Hurwitz H., Fehrenbacher L., Novotny W., Cartwright T., Hainsworth J., Heim W., et al. Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 2004; 350: 2335–42
- Folprecht G., Grothey A., Alberts S., Raab H. R., Höhne C. H. Neoadjuvant treatment of unresectable colorectal liver metastases: correlation between tumour response and resection rates. Ann Oncol 2005; 16: 1311–9
- Wagner J. S., Adson M. A., Van Heerden J. A., Adson M. H., Ilstrup D. M. The natural history of hepatic metastases from colorectal cancer. Ann Surg 1984; 199: 502–7